Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

423 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Infection of macrophages and dendritic cells with primary R5-tropic human immunodeficiency virus type 1 inhibited by natural polyreactive anti-CCR5 antibodies purified from cervicovaginal secretions.
Eslahpazir J, Jenabian MA, Bouhlal H, Hocini H, Carbonneil C, Grésenguet G, Mbopi Kéou FX, LeGoff J, Saïdi H, Requena M, Nasreddine N, de Dieu Longo J, Kaveri SV, Bélec L. Eslahpazir J, et al. Among authors: belec l. Clin Vaccine Immunol. 2008 May;15(5):872-84. doi: 10.1128/CVI.00463-07. Epub 2008 Mar 19. Clin Vaccine Immunol. 2008. PMID: 18353923 Free PMC article.
Pre-clinical development as microbicide of zinc tetra-ascorbo-camphorate, a novel terpenoid derivative: potent in vitro inhibitory activity against both R5- and X4-tropic HIV-1 strains without significant in vivo mucosal toxicity.
Saïdi H, Jenabian MA, Gombert B, Charpentier C, Mannarini A, Bélec L. Saïdi H, et al. Among authors: belec l. AIDS Res Ther. 2008 Jun 3;5:10. doi: 10.1186/1742-6405-5-10. AIDS Res Ther. 2008. PMID: 18522743 Free PMC article.
In vitro synergistic activity against CCR5-tropic HIV-1 with combinations of potential candidate microbicide molecules HHA, KRV2110 and enfuvirtide (T20).
Jenabian MA, Saïdi H, Charpentier C, Van Herrewege Y, Son JC, Schols D, Balzarini J, Vanham G, Bélec L; ANRS Multi-Micro Project Study Group. Jenabian MA, et al. Among authors: belec l. J Antimicrob Chemother. 2009 Dec;64(6):1192-5. doi: 10.1093/jac/dkp380. Epub 2009 Oct 29. J Antimicrob Chemother. 2009. PMID: 19875507
Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic.
Charpentier C, Gody JC, Mbitikon O, Moussa S, Matta M, Péré H, Fournier J, Longo Jde D, Bélec L. Charpentier C, et al. Among authors: belec l. AIDS Res Hum Retroviruses. 2012 Jan;28(1):87-94. doi: 10.1089/aid.2011.0035. Epub 2011 Jun 20. AIDS Res Hum Retroviruses. 2012. PMID: 21599597
423 results